(+/-)-2,5-DIMETHOXY-4-BROMO-AMPHETAMINE HYDROBROMIDE
한글명:(+/-)-2,5-DIMETHOXY-4-BROMO-AMPHETAMINE HYDROBROMIDE
카스 번호53581-53-6
상품명:(+/-)-2,5-DIMETHOXY-4-BROMO-AMPHETAMINE HYDROBROMIDE
CBNumberCB3246311
분자식C11H17Br2NO2
포뮬러 무게355.07
MOL 파일53581-53-6.mol
| 위험품 표기 | T+ |
| 위험 카페고리 넘버 | 26/27/28 |
| 안전지침서 | 28-36/37-45 |
| 유엔번호(UN No.) | UN 2811 6.1/PG 2 |
| WGK 독일 | 3 |
| RTECS 번호 | SH0300000 |
| 위험 등급 | 6.1(a) |
| 포장분류 | I |
| 독성 | A hallucinogenic (psychedelic) agent that is obtained by chemical synthesis. It may catalyze severe emotional problems or psychosis in predisposed individuals, and in large doses, produces peripheral arterial spasm which, if not treated, can lead to gangrene. DOB is a potent serotonin 5-HT2 agonist, and although the underlying mechanism of action for hallucinogens is not well understood, this may be related to its actions in the CNS. Symptoms include hyperreflexia, restlessness, perceptual alterations, and illusions, including changes in touch, taste, and odor, and the thinking process is substantially altered. At high doses, it causes hallucinations, loss of contact with reality, and pain and coldness in the extremities at toxic levels. Therapeutically, peripheral arterial spasm has been treated with intraarterial tolazoline hydrochloride. Its LD50 is in mice 80 mg/kg, i.v., in rats 8 mg/kg, i.p., in dogs 4 mg/kg. i.v., and in monkeys 2 mg/kg, i.v. |
